AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AP2B1 | Adaptor-related protein complex 2, beta 1 subunit | Cancer-related genes
| | | | | Expressed in all |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
APPBP2 | Amyloid beta precursor protein (cytoplasmic tail) binding protein 2 | Cancer-related genes
| | | | | Expressed in all |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins
| | | | | Group enriched |
ARHGAP35 | Rho GTPase activating protein 35 | Cancer-related genes
| | | | | Expressed in all |
ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ASPSCR1 | Alveolar soft part sarcoma chromosome region, candidate 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ASXL2 | Additional sex combs like 2 (Drosophila) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ATF1 | Activating transcription factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATR | Ataxia telangiectasia and Rad3 related | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BAD | BCL2-associated agonist of cell death | Cancer-related genes Mitochondrial proteins RAS pathway related proteins
| | | | | Expressed in all |
BAG1 | BCL2-associated athanogene | Cancer-related genes
| | | | | Expressed in all |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
BARD1 | BRCA1 associated RING domain 1 | Cancer-related genes Plasma proteins
| | | | | Mixed |
BAX | BCL2-associated X protein | Cancer-related genes Mitochondrial proteins Transporters
| | | | | Expressed in all |
BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Mixed |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
BCL2 | B-cell CLL/lymphoma 2 | Cancer-related genes Disease related genes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BCL3 | B-cell CLL/lymphoma 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
BCL6 | B-cell CLL/lymphoma 6 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
BCL7A | B-cell CLL/lymphoma 7A | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
BCR | Breakpoint cluster region | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes
| | | | | Group enriched |
BIRC2 | Baculoviral IAP repeat containing 2 | Cancer-related genes
| | | | | Expressed in all |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Mixed |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes
| | | | | Mixed |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |